Fine Mark National Bank & Trust Cyto Dyn Inc. Transaction History
Fine Mark National Bank & Trust
- $2.81 Billion
- Q4 2024
A detailed history of Fine Mark National Bank & Trust transactions in Cyto Dyn Inc. stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 15,000 shares of CYDY stock, worth $3,150. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$3,150% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CYDY
# of Institutions
10Shares Held
278KCall Options Held
0Put Options Held
0-
Mai Capital Management47.5KShares$9,9710.0% of portfolio
-
Diversified Trust CO45.8KShares$9,6150.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY45KShares$9,4500.0% of portfolio
-
Rfp Financial Group LLC Atlanta, GA41.5KShares$8,7040.0% of portfolio
-
Next Capital Management LLC32.5KShares$6,8250.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $171M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...